Literature DB >> 33582896

Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation.

Fosca Quarti-Trevano1, Gino Seravalle1, Raffaella Dell'Oro1, Giuseppe Mancia2, Guido Grassi3.   

Abstract

PURPOSE OF REVIEW: To review the results of studies of the effects of dialysis and kidney transplantation on the autonomic nervous system alterations that occur in chronic kidney disease. RECENT
FINDINGS: Vagal control of the heart mediated by arterial baroreceptors is altered early in the course of the renal disease. Sympathetic activation occurs, with increases in resting heart rate, venous plasma norepinephrine levels, muscle sympathetic nerve traffic, and other indirect indices of adrenergic drive. The magnitude of the changes reflects the clinical severity of the kidney disease. Both the sympathetic and parasympathetic alterations have a reflex origin, depending on the impairment in baroreflex and cardiopulmonary reflex control of the cardiovascular system. These alterations are partially reversed during acute hemodialysis, but the responses are variable depending on the specific type of dialytic treatment that is employed. Renal transplantation improves reflex cardiovascular control, resulting in sympathoinhibition following renal transplantation if the native kidneys are removed. Sympathoinhibitory effects have been also reported in renal failure patients after bilateral renal denervation. Assessment of autonomic nervous system responses to dialysis and renal transplantation provides information of clinical interest, given the evidence that autonomic alterations are involved in the development and progression of cardiovascular complications, as well as in the prognosis of chronic kidney disease.

Entities:  

Keywords:  Baroreflex; Cardiopulmonary reflex; Hemodialysis; Prognosis; Renal denervation; Renal failure; Renal transplantation; Sympathetic nervous system

Year:  2021        PMID: 33582896      PMCID: PMC7882573          DOI: 10.1007/s11906-021-01129-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

1.  Mechanisms of sympathetic overactivity in patients with chronic renal failure: a role for chemoreflex activation?

Authors:  Martin Hausberg; Guido Grassi
Journal:  J Hypertens       Date:  2007-01       Impact factor: 4.844

2.  Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.

Authors:  Guido Grassi; Gino Seravalle; Lorenzo Ghiadoni; Giovanni Tripepi; Rosa Maria Bruno; Giuseppe Mancia; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

3.  Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment.

Authors:  Laima Siddiqi; Niek H Prakken; Birgitta K Velthuis; Maarten J Cramer; P Liam Oey; Peter Boer; Michiel L Bots; Peter J Blankestijn
Journal:  Nephrol Dial Transplant       Date:  2010-03-31       Impact factor: 5.992

4.  Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.

Authors:  U Scherrer; S F Vissing; B J Morgan; J A Rollins; R S Tindall; S Ring; P Hanson; P K Mohanty; R G Victor
Journal:  N Engl J Med       Date:  1990-09-13       Impact factor: 91.245

Review 5.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 6.  Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV.

Authors:  Reena Ranpuria; Martica Hall; Chris T Chan; Mark Unruh
Journal:  Nephrol Dial Transplant       Date:  2007-11-14       Impact factor: 5.992

7.  Sympathetic nerve activity is inappropriately increased in chronic renal disease.

Authors:  Inge H H T Klein; Gerry Ligtenberg; Jutta Neumann; P Liam Oey; Hein A Koomans; Peter J Blankestijn
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

8.  Heart rate as marker of sympathetic activity.

Authors:  G Grassi; S Vailati; G Bertinieri; G Seravalle; M L Stella; R Dell'Oro; G Mancia
Journal:  J Hypertens       Date:  1998-11       Impact factor: 4.844

9.  Improvement of cardiac sympathetic innervation by renal transplantation.

Authors:  Chinori Kurata; Akihiko Uehara; Akira Ishikawa
Journal:  J Nucl Med       Date:  2004-07       Impact factor: 10.057

10.  Effect of end-stage renal disease on decreased heart rate variability.

Authors:  A A Steinberg; R L Mars; D S Goldman; R F Percy
Journal:  Am J Cardiol       Date:  1998-11-01       Impact factor: 2.778

View more
  5 in total

1.  Vagally Associated Second Degree Atrio-Ventricular Block in a Dog with Severe Azotemia and Evidence of Sympathetic Overdrive.

Authors:  Radu Andrei Baisan; Andreea Cătălina Turcu; Eusebiu Ionuț Condurachi; Vasile Vulpe
Journal:  Vet Sci       Date:  2022-05-05

Review 2.  The sympathies of the body: functional organization and neuronal differentiation in the peripheral sympathetic nervous system.

Authors:  Uwe Ernsberger; Thomas Deller; Hermann Rohrer
Journal:  Cell Tissue Res       Date:  2021-11-10       Impact factor: 5.249

3.  Ambulatory blood pressure trajectories and blood pressure variability in kidney transplant recipients: a comparative study against chronic kidney disease patients.

Authors:  Maria Korogiannou; Marieta Theodorakopoulou; Pantelis Sarafidis; Maria Eleni Alexandrou; Eva Pella; Efstathios Xagas; Antonis Argyris; Athanase Protogerou; Aikaterini Papagianni; Ioannis N Boletis; Smaragdi Marinaki
Journal:  Kidney Res Clin Pract       Date:  2022-06-22

4.  Renal Transplantation in Pure Autonomic Failure.

Authors:  Zain Ul Abideen; Anna Rixon; Nirosha D Gunatillake; Elizabeth Househam; Christopher J Mathias; Andrew Connor
Journal:  Transplant Direct       Date:  2022-08-04

5.  Insight on Efficacy of Renal Artery Denervation for Refractory Hypertension with Chronic Kidney Diseases: A Long-Term Follow-Up of 24-Hour Ambulatory Blood Pressure.

Authors:  Han Cai; Zhoufei Fang; Ruofan Lin; Wenqin Cai; Ying Han; Jinzi Su
Journal:  J Interv Cardiol       Date:  2022-09-21       Impact factor: 1.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.